Cerus Corp CERS

US Health Care

$2.15 ▼ -25.61% ($-0.74)

⬇️ Below Yest. Low

Open $2.43

Prev Close $2.89

Day Range $2.06 – $2.46

52W Range $1.15 – $3.47

Market Cap $430.79M

Beta 1.77

EPS (TTM) $-0.05

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	1997-01-31
Shares Out.	200,370,000
Website	cerus.com/ ↗
Phone	13026587581
Employees	345
Revenue	$59.9M
Gross Profit	$34.1M
Net Income	-$1.6M
Free Cash Flow	-$1.2M
Total Assets	$222.9M
Total Liabilities	$154.6M
Equity	$68.3M

About Cerus Corp

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.

Cerus Corp is a publicly traded company under the ticker symbol CERS on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.